I know this forum is about the stock, but I think many of us forget the money entirely when it comes to the MPS indication. If our investment helps provide impactful treatment to MPS sufferers, including pediatric patients, we've all been part of something genuinely good here.
Ann: FIRST PATIENT DOSED IN MPS-I PHASE 2 CLINICAL TRIAL, page-15
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.73M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.5¢ | 22.0¢ | $34.69K | 154.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 28174 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 25000 | 1 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |